Syphilis: stages, diagnosis, treatment and complete clinical management
On this page
01
Overview
Syphilis is a chronic, systemic infection caused by the motile spirochaete Treponema pallidum, spread mainly through sexual contact with an infectious lesion and vertically across the placenta. It evolves through primary, secondary, latent and tertiary stages — which can overlap — and neurosyphilis or ocular disease may occur at any stage. A painless ulcer that has healed does not exclude infection.
Every patient with syphilis needs HIV testing, a sexual-exposure history, neurological/ocular review, pregnancy assessment where relevant, and a plan for partner notification.
02
Learning objectives
- Recognise the stages and infectiousness of syphilis.
- Interpret treponemal and non-treponemal tests, including titre changes after treatment.
- Diagnose and manage neurosyphilis, ocular/otosyphilis and congenital syphilis.
- Choose stage-appropriate penicillin treatment and manage allergy, pregnancy and follow-up.
- Prevent reinfection through partner management, safer sex and antenatal screening.
03
Organism, transmission and pathogenesis
T. pallidum enters through microscopic breaks in skin or mucosa, multiplies locally, then spreads through lymphatics and bloodstream and can persist for decades. Transmission is through vaginal, anal or oral sex, direct contact with mucous patches or condylomata lata, and vertically across the placenta. The organism is fragile outside the body — fomites are not an important route.
Scroll the table sideways on a smaller screen.
| Stage | Key findings | Infectiousness |
|---|---|---|
| Primary | Solitary or multiple chancre with regional nodes | High at the lesion |
| Secondary | Generalised rash, mucous patches, condylomata lata, systemic symptoms | Very high |
| Early latent | No symptoms; infection acquired within the past year | Meaningful sexual/vertical risk |
| Late latent | Asymptomatic infection of longer duration | Low sexual risk; ongoing fetal risk |
| Tertiary | Gummas, cardiovascular disease, neurosyphilis | Usually not sexually infectious |
04
Clinical stages
Primary syphilis
After an incubation of roughly 10–90 days, a chancre appears at the inoculation site — classically painless, indurated and clean-based, with non-tender regional lymphadenopathy. Rectal, cervical, oral or vaginal chancres may be hidden or mistaken for trauma, herpes or malignancy. The chancre heals spontaneously in two to six weeks without eradicating the infection.
Secondary syphilis
Haematogenous dissemination produces fever, malaise, headache, generalised lymphadenopathy and a diffuse rash that characteristically involves the palms and soles (it may be subtle in dark skin). Mucous patches, broad moist condylomata lata, patchy alopecia, hepatitis, nephritis, uveitis and meningitis can occur. Symptoms may relapse if untreated.
Latent syphilis
No clinical signs, but serology remains positive. Classify as early or late using documented symptoms, previous negative testing or a credible recent exposure; if timing is uncertain, manage as late latent / unknown duration.
Tertiary disease
Gummas are destructive granulomas of skin, bone or viscera. Cardiovascular disease includes aortitis, aneurysm and aortic-valve insufficiency. Neurosyphilis presents as meningitis, meningovascular stroke, tabes dorsalis or general paresis.
05
Neuro, ocular and otic disease
Suspect neurosyphilis with cranial-nerve palsy, meningitis, stroke in a young adult, altered cognition, sensory ataxia, lightning pains or unexplained psychiatric change. Ocular syphilis causes uveitis, retinitis, optic neuritis or vision loss; otosyphilis causes tinnitus, vertigo or sensorineural hearing loss. Ocular and otic disease are treated as neurosyphilis, with urgent ophthalmology or ENT input — do not delay treatment while awaiting cerebrospinal-fluid results when sight or hearing is threatened.
06
Diagnosis
- Always use both a non-treponemal test (RPR or VDRL) and a treponemal test (TPPA/TPHA or EIA/CLIA) — one test alone is insufficient for staging and treatment decisions.
- RPR/VDRL titres reflect disease activity and monitor response; treponemal tests usually remain positive for life.
- Dark-field microscopy or lesion PCR, where available, can confirm early disease, but a negative result does not exclude it.
- Lumbar puncture when neurological signs, ocular/otic disease, tertiary disease or treatment failure raises concern; interpret CSF cell count, protein and CSF-VDRL with serum results.
- Test for HIV and other STIs; check pregnancy; evaluate hepatitis or renal disease when indicated.
07
Management
Primary, secondary and early latent syphilis
Benzathine penicillin G 2.4 million units IM as a single dose — the standard regimen. Use the correct formulation (benzathine, not procaine or aqueous) and give deep into a large muscle, dividing the dose between two sites if needed.
Late latent or unknown duration
Benzathine penicillin G 2.4 million units IM weekly for 3 doses (7-day intervals). If a dose is substantially delayed, restart the schedule according to guideline and document every dose.
Neurosyphilis and ocular/otic syphilis
Aqueous crystalline penicillin G IV — typically 18–24 million units per day (3–4 million units every 4 hours or continuous infusion) for 10–14 days — under specialist care. An alternative is procaine penicillin 2.4 million units IM daily with probenecid 500 mg four times daily for 10–14 days. Routine benzathine penicillin alone is inadequate for neurosyphilis.
Penicillin allergy
In non-pregnant patients with confirmed early disease and no neurosyphilis, a guideline-approved alternative such as doxycycline may be used. Pregnancy and neurosyphilis require penicillin desensitisation — there is no adequate substitute.
08
Drug summary table
Scroll the table sideways on a smaller screen.
| Drug / regimen | Dose and duration | Indication | Adverse effects / cautions |
|---|---|---|---|
| Benzathine penicillin G | 2.4 million units IM single dose (primary, secondary, early latent); 2.4 million units IM weekly ×3 (late latent/unknown duration) | All non-neurological syphilis; drug of choice in pregnancy | Injection-site pain; Jarisch–Herxheimer reaction; confirm the formulation is benzathine — never substitute short-acting forms |
| Aqueous crystalline penicillin G | 3–4 million units IV every 4 h (or continuous infusion totalling 18–24 MU/day) ×10–14 days | Neurosyphilis, ocular and otic syphilis | Requires admission/infusion setup and specialist monitoring |
| Procaine penicillin + probenecid | 2.4 million units IM daily + probenecid 500 mg QDS ×10–14 days | Alternative when IV penicillin unavailable for neurosyphilis | Probenecid: GI upset, renal-stone risk; avoid in significant renal impairment and in pregnancy unless directed |
| Doxycycline | 100 mg orally twice daily ×14 days (early disease); ×28 days (late latent) | Penicillin-allergic, non-pregnant adults with no neurosyphilis | Photosensitivity, oesophagitis; ineffective for neurosyphilis; avoid in pregnancy and breastfeeding |
| Ceftriaxone | 1–2 g IM/IV daily ×10–14 days | Occasional specialist alternative when penicillin unusable | Cross-reactivity with penicillin allergy is possible; confirm current guideline before use |
These regimens follow international guidance; always confirm the current Uganda Clinical Guidelines schedule and locally available formulations before prescribing.
09
Pregnancy and congenital syphilis
Penicillin is the only proven treatment that prevents congenital syphilis. Screen at the first antenatal visit and repeat later in pregnancy or at delivery according to national policy and risk. Treat promptly — do not wait for the partner. Ultrasound may show fetal anaemia, hepatomegaly, placentomegaly or hydrops, but a normal scan does not exclude fetal infection. Evaluate exposed infants with paediatrics: physical examination, quantitative serology, long-bone X-rays and treatment based on maternal stage, treatment timing and infant findings.
10
Jarisch–Herxheimer reaction
Within 24 hours of therapy, fever, chills, myalgia, headache or transient rash may occur from cytokine release as spirochaetes die. It is not penicillin allergy. Provide fluids, antipyretics and observation. In pregnancy it may precipitate contractions or fetal distress — treat syphilis promptly and monitor obstetrically rather than withholding therapy.
11
Follow-up and partner management
- Repeat quantitative RPR/VDRL at guideline-defined intervals (commonly 6 and 12 months), using the same test and laboratory where possible.
- Assess for a fourfold titre decline, persistent symptoms, treatment failure and reinfection; re-test HIV if risk continues.
- Partners exposed during the infectious period need confidential notification, examination, serology and presumptive treatment when indicated.
- Advise abstinence until lesions have healed and partners assessed/treated; condoms reduce but do not eliminate risk because lesions may lie outside covered areas.
12
Clinical scenario
Scenario 1 — Rash on palms and soles
A 26-year-old man has two weeks of malaise, fever, generalised lymphadenopathy and a painless rash involving his palms and soles. He recalls a genital ulcer three months ago that healed by itself. RPR titre is 1:64 and TPPA is positive — secondary syphilis. You treat with benzathine penicillin G 2.4 million units IM as a single dose, test for HIV (positive — syphilis and HIV potentiate each other’s transmission), counsel about the Jarisch–Herxheimer reaction he may develop within 24 hours, and arrange partner notification and follow-up titres at 6 and 12 months. The self-healed ulcer did not mean self-cure.
Scenario 2 — A painful eye and a positive RPR
A 34-year-old woman presents with a painful red eye and blurred vision; RPR is positive at 1:128. Ocular syphilis is a treatment emergency: refer urgently to ophthalmology and treat as neurosyphilis with aqueous penicillin G IV for 10–14 days — benzathine penicillin alone would undertreat her. You do not wait for the lumbar puncture result before starting. HIV testing, a neurological examination and partner management complete the encounter.
13
Key points
14
References
- SlideShare: Syphilis lecture (Library reference.)
- Uganda Clinical Guidelines: syphilis management (Library reference.)
- WHO and current national STI guidance (Library reference.)
- Centers for Disease Control and Prevention STI Treatment Guidelines (Library reference.)
Safety note: confirm current Uganda dosing, laboratory algorithms and congenital-syphilis protocols before prescribing.
15
Further reading
For deeper study, compare this lesson with current guidance and standard references from recognised medical and public-health organisations.
For education only. Apply current Uganda Clinical Guidelines, local protocols and specialist advice in clinical practice.